Css LLC Incyte Corp Call Options Transaction History

Css LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $1.2 Million - $1.46 Million	-14,500 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $748,480 - $932,800	-8,000 Reduced 35.56%	14,500 $1.37 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $2.46 Million - $3.11 Million	22,500	22,500 $2.63 Million

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.